Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Avalo Therapeutics Inc AVTX

Healthcare Biotechnology
Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. Its lead asset includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its... see more

Current News (NDAQ:AVTX)

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire November 17, 2025

Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates

GlobeNewswire November 6, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire November 3, 2025

Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa

GlobeNewswire October 29, 2025

Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources

GlobeNewswire October 1, 2025

Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors

GlobeNewswire September 22, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire August 27, 2025

Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates

GlobeNewswire August 7, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire June 23, 2025
View More News ››

Opinion & Analysis (NDAQ:AVTX)

Cerecor Shares Rise 13% on Sale of Pediatric Portfolio for $32 Million

Streetwise Reports October 16, 2019
View More Opinion ››

Bullboard Posts (NDAQ:AVTX)

AVTX....sold all into the strength to the high of $27

It's been an absolute pleasure I can honestly say this was my biggest win in a while ; ) Thanks 
Iseneschal - March 28, 2024

RE:AVTX....... $21 Holla !!!!!!!!!!!!!!!!!

Let me re-phrase that .... I'd just woke up ; ) I just wanted to mention the fact again that billlionaire Steven Cohen is a...
Iseneschal - March 28, 2024

AVTX....... $21 Holla !!!!!!!!!!!!!!!!!

I wonder if the influential shareholder Steve Cohen feels  right now ?
Iseneschal - March 28, 2024

AVTX......Your time HAS come!!!!!!!

Your Time Is Gonna Come (Remaster) (youtube.com)
Iseneschal - March 27, 2024

AVTX....Holy Mother of Haysues !!!!!!!!!!!!!!!!!!!!!!!!!

Ka F'king boooooooom !!!!!
Iseneschal - March 27, 2024

AVTX..... Just 1 of a few influential Shareholders... Look !

ir.avalotx.com/sec-filings-email/content/0000902664-24-001630/p24-0787sc13ga.htm Steven A. Cohen - Search (bing.com)
Iseneschal - March 9, 2024
View more Bullboard ››

Sranan Gold Corp.

Sranan Gold Corp.

Sranan Gold Corp. develops, acquires, and explores mineral properties in Canada. The company primarily explores gold deposits ...
View More »

Podcasts